![](/img/cover-not-exists.png)
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
Corno, Cristina, Stucchi, Simone, De Cesare, Michelandrea, Carenini, Nives, Stamatakos, Serena, Ciusani, Emilio, Minoli, Lucia, Scanziani, Eugenio, Argueta, Christian, Landesman, Yosef, Zaffaroni, NadLanguage:
english
Journal:
Biochemical Pharmacology
DOI:
10.1016/j.bcp.2017.11.009
Date:
November, 2017
File:
PDF, 1.93 MB
english, 2017